Mesenchymal stem cells for graft vs. host disease (UMC Utrecht)
This trial aims to investigate the potential of mesenchymal stem cells (MSCs) in treating patients with steroid-resistant graft vs host disease. MSCs will be expanded by human platelet lysate and plasma.
Read More
The cells were not characterized by the sponsor.
Read More
Product Information for
Mesenchymal stem cells for graft vs. host disease (UMC Utrecht)